Skip to content

Celcuity CELC Preferred Stock, Shares Authorized

Preferred Stock, Shares Authorized at other companies

Gilead Sciences logo
Gilead SciencesGILD
BridgeBio Pharma logo
BridgeBio PharmaBBIO
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
Exelixis logo
ExelixisEXEL
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.4B+1,370%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's preferred stock, shares authorized.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's preferred stock, shares authorized?
Celcuity (CELC) reported preferred stock, shares authorized of $2.5M in Q1 2026.
How has Celcuity's preferred stock, shares authorized changed year-over-year?
Celcuity's preferred stock, shares authorized decreased by 0.0% year-over-year, from $2.5M to $2.5M.
What is the long-term trend for Celcuity's preferred stock, shares authorized?
Over 5 years (2020 to 2025), Celcuity's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $2.5M to $2.5M.